Literature DB >> 27672486

The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis.

Nazanin Arjomand Fard1, Gholamreza Azizi1, Abbas Mirshafiey1.   

Abstract

Multiple sclerosis is a complex disease with many different immune cells involved in its pathogenesis. Newly identified T helper cell 22 (Th22) is a subset of CD4(+) T cells with specific properties apart from other known CD4(+) T cell subsets with distinguished function and gene expression. Th22 cells are characterized by production of a distinct profile of effector cytokines, including interleukin (IL)-22, IL-13, and tumor necrosis factor-α (TNF- α). The frequency of Th22 and related cytokine IL-22 are increased in various autoimmune diseases. Recently, several studies have reported the changes in frequency and function of Th22 in multiple sclerosis. This review discusses the role of Th22 and its cytokine IL-22 in the immunopathogenesis of multiple sclerosis disease.

Entities:  

Keywords:  T helper 22; interleukin-22; multiple sclerosis

Year:  2016        PMID: 27672486      PMCID: PMC5022987     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  48 in total

Review 1.  The genetics of multiple sclerosis.

Authors:  A Compston
Journal:  Clin Chem Lab Med       Date:  2000-02       Impact factor: 3.694

Review 2.  Canonical and non-canonical Notch signaling in CD4⁺ T cells.

Authors:  Lisa M Minter; Barbara A Osborne
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 3.  Toward the development of rational therapies in multiple sclerosis: what is on the horizon?

Authors:  Bernhard Hemmer; Hans-Peter Hartung
Journal:  Ann Neurol       Date:  2007-10       Impact factor: 10.422

Review 4.  Plasticity of CD4+ T cell lineage differentiation.

Authors:  Liang Zhou; Mark M W Chong; Dan R Littman
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

5.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

6.  N-acetylglucosamine inhibits T-helper 1 (Th1)/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis.

Authors:  Ani Grigorian; Lindsey Araujo; Nandita N Naidu; Dylan J Place; Biswa Choudhury; Michael Demetriou
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

Review 7.  IL-22, not simply a Th17 cytokine.

Authors:  Sascha Rutz; Céline Eidenschenk; Wenjun Ouyang
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

8.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

Review 9.  The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

Authors:  Howard L Weiner
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

10.  Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat.

Authors:  Beatriz Almolda; Manuela Costa; Maria Montoya; Berta González; Bernardo Castellano
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

View more
  3 in total

Review 1.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis.

Authors:  Mahmood Y Hachim; Noha M Elemam; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

3.  The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis.

Authors:  Wessam Mustafa; Nadia Elgendy; Samer Salama; Mohamed Jawad; Khaled Eltoukhy
Journal:  Mult Scler Int       Date:  2021-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.